367 related articles for article (PubMed ID: 8943389)
1. CD40, but not lipopolysaccharide and anti-IgM stimulation of primary B lymphocytes, leads to a persistent nuclear accumulation of RelB.
Neumann M; Wohlleben G; Chuvpilo S; Kistler B; Wirth T; Serfling E; Schimpl A
J Immunol; 1996 Dec; 157(11):4862-9. PubMed ID: 8943389
[TBL] [Abstract][Full Text] [Related]
2. Dominant signals leading to inhibitor kappaB protein degradation mediate CD40 ligand rescue of WEHI 231 immature B cells from receptor-mediated apoptosis.
Schauer SL; Bellas RE; Sonenshein GE
J Immunol; 1998 May; 160(9):4398-405. PubMed ID: 9574544
[TBL] [Abstract][Full Text] [Related]
3. Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes.
Hsing Y; Hostager BS; Bishop GA
J Immunol; 1997 Nov; 159(10):4898-906. PubMed ID: 9366415
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of the transcription factor NF-kappaB during human mononuclear phagocyte differentiation to macrophages and dendritic cells.
Ammon C; Mondal K; Andreesen R; Krause SW
Biochem Biophys Res Commun; 2000 Feb; 268(1):99-105. PubMed ID: 10652220
[TBL] [Abstract][Full Text] [Related]
5. Induction of nuclear factor-kappa B during primary B cell differentiation.
Kistler B; Rolink A; Marienfeld R; Neumann M; Wirth T
J Immunol; 1998 Mar; 160(5):2308-17. PubMed ID: 9498771
[TBL] [Abstract][Full Text] [Related]
6. The subunit composition of NF-kappa B complexes changes during B-cell development.
Grumont RJ; Gerondakis S
Cell Growth Differ; 1994 Dec; 5(12):1321-31. PubMed ID: 7696180
[TBL] [Abstract][Full Text] [Related]
7. The evolutionarily conserved sequence upstream of the human Ig heavy chain S gamma 3 region is an inducible promoter: synergistic activation by CD40 ligand and IL-4 via cooperative NF-kappa B and STAT-6 binding sites.
Schaffer A; Cerutti A; Shah S; Zan H; Casali P
J Immunol; 1999 May; 162(9):5327-36. PubMed ID: 10228008
[TBL] [Abstract][Full Text] [Related]
8. Differential nuclear localization of p50, p52, and RelB proteins in human accessory cells of the immune response in situ.
Feuillard J; Körner M; Israel A; Vassy J; Raphael M
Eur J Immunol; 1996 Nov; 26(11):2547-51. PubMed ID: 8921937
[TBL] [Abstract][Full Text] [Related]
9. Role for CD40-mediated activation of c-Rel and maintenance of c-myc RNA levels in mitigating anti-IgM-induced growth arrest.
Siebelt F; Berberich I; Shu G; Serfling E; Clark EA
Cell Immunol; 1997 Oct; 181(1):13-22. PubMed ID: 9344491
[TBL] [Abstract][Full Text] [Related]
10. Distinct NF-kappa B/Rel transcription factors are responsible for tissue-specific and inducible gene activation.
Lernbecher T; Müller U; Wirth T
Nature; 1993 Oct; 365(6448):767-70. PubMed ID: 7692309
[TBL] [Abstract][Full Text] [Related]
11. Regulation of intercellular adhesion molecule-1 gene by tumor necrosis factor-alpha is mediated by the nuclear factor-kappaB heterodimers p65/p65 and p65/c-Rel in the absence of p50.
Aoudjit F; Brochu N; Bélanger B; Stratowa C; Hiscott J; Audette M
Cell Growth Differ; 1997 Mar; 8(3):335-42. PubMed ID: 9056676
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide from Salmonella enterica activates NF-kappaB through both classical and alternative pathways in primary B Lymphocytes.
Souvannavong V; Saidji N; Chaby R
Infect Immun; 2007 Oct; 75(10):4998-5003. PubMed ID: 17698569
[TBL] [Abstract][Full Text] [Related]
13. Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways.
Zarnegar B; He JQ; Oganesyan G; Hoffmann A; Baltimore D; Cheng G
Proc Natl Acad Sci U S A; 2004 May; 101(21):8108-13. PubMed ID: 15148378
[TBL] [Abstract][Full Text] [Related]
14. Maintenance of nuclear factor-kappa B/Rel and c-myc expression during CD40 ligand rescue of WEHI 231 early B cells from receptor-mediated apoptosis through modulation of I kappa B proteins.
Schauer SL; Wang Z; Sonenshein GE; Rothstein TL
J Immunol; 1996 Jul; 157(1):81-6. PubMed ID: 8683159
[TBL] [Abstract][Full Text] [Related]
15. Deficient translocation of c-Rel is associated with impaired Th1 cytokine production in T cells from atopic dermatitis patients.
Dieckhoff K; Graf P; Beinhauer B; Schwaerzler C; Carballido JM; Neumann C; Zachmann K; Jung T
Exp Dermatol; 2005 Jan; 14(1):17-25. PubMed ID: 15660915
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells.
Marienfeld R; Neumann M; Chuvpilo S; Escher C; Kneitz B; Avots A; Schimpl A; Serfling E
Eur J Immunol; 1997 Jul; 27(7):1601-9. PubMed ID: 9247567
[TBL] [Abstract][Full Text] [Related]
17. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
Sovak MA; Bellas RE; Kim DW; Zanieski GJ; Rogers AE; Traish AM; Sonenshein GE
J Clin Invest; 1997 Dec; 100(12):2952-60. PubMed ID: 9399940
[TBL] [Abstract][Full Text] [Related]
18. Transcription of the RelB gene is regulated by NF-kappaB.
Bren GD; Solan NJ; Miyoshi H; Pennington KN; Pobst LJ; Paya CV
Oncogene; 2001 Nov; 20(53):7722-33. PubMed ID: 11753650
[TBL] [Abstract][Full Text] [Related]
19. Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells.
Soro PG; Morales-A P; Martínez-M JA; Morales-A S; Copín SG; Marcos MA; Gaspar ML
J Immunol; 1999 Jul; 163(2):611-7. PubMed ID: 10395648
[TBL] [Abstract][Full Text] [Related]
20. Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expression.
Durandy A; Hivroz C; Mazerolles F; Schiff C; Bernard F; Jouanguy E; Revy P; DiSanto JP; Gauchat JF; Bonnefoy JY; Casanova JL; Fischer A
J Immunol; 1997 Mar; 158(6):2576-84. PubMed ID: 9058789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]